About Quince Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://quincetx.com/
Frequently Asked Questions
What is the 52-week range for QNCX?
The 52-week high is $910 and the 52-week low is $15.1.
What is the P/E ratio for QNCX?
The P/E ratio data is currently unavailable.
What is the dividend yield for QNCX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -127.02%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 2.73.
Analyst Recommendation Trends
Wall Street analyst consensus for QNCX over the last few months:
Latest QNCX News
Quince Therapeutics, Inc. (QNCX) Discusses LAM-001 Clinical Progress in Pulmonary Hypertension and Bronchiolitis Obliterans Syndrome Transcript
Quince Therapeutics, Inc. (QNCX) Discusses LAM-001 Clinical Progress in Pulmonary Hypertension and Bronchiolitis Obliterans Syndrome September 28, 2026...
Microsoft reinstated, Ralph Lauren upgraded: Wall Street's top analyst calls
Microsoft reinstated, Ralph Lauren upgraded: Wall Street's top analyst calls
This Ares Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts initiated coverage: ARES Overweight, $150; MGEE Neutral, $76; TTRX Buy, $24; QNCX Buy, $70; EFSC Buy, $70.
Rodman & Renshaw Initiates Coverage On Quince Therapeutics with Buy Rating, Announces Price Target of $70
Rodman & Renshaw analyst Seema Sheoran initiates coverage on Quince Therapeutics (NASDAQ:QNCX) with a Buy rating and announces Price Target of $70.
Netflix downgraded, SanDisk initiated: Wall Street's top analyst calls
Netflix downgraded, SanDisk initiated: Wall Street's top analyst calls
Citizens Upgrades Quince Therapeutics to Market Outperform, Announces $77 Price Target
Citizens analyst Jonathan Wolleben upgrades Quince Therapeutics (NASDAQ:QNCX) from Market Perform to Market Outperform and announces $77 price target.
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Decoy Therapeutics (NASDAQ:DCOY) shares rose 84.0% to $4.71 during Tuesday's pre-market session. The company's market cap stands at $1.6 million. Greenland Mines (NASDAQ:GRML) shares rose 39.21% to
Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious, underserved diseases, today announced that it will host a virtual key opinion leader (KOL) event on Monday, September 28, 2026 from 12:30-2:00 PM ET. The event will feature PH-ILD experts Aaron B. Waxman, MD, PhD (Brigham and Women's Hospital) and Paul Yu, MD, PhD (Massach
Quince Therapeutics Receives Nasdaq Noncompliance Notice, Gets Time Through Oct. 15 To Regain Compliance
SEC.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-06-11 | Lamond David | +2,700 | - | - |
| 2026-06-11 | Senner Christopher J. | +2,700 | - | - |
| 2026-05-18 | Roberts Brigette | +6,837,319 | - | - |
| 2026-05-18 | Roberts Brigette | +6,837,319 | - | - |
| 2026-05-18 | Roberts Brigette | +2,070,107 | - | - |
| 2026-05-18 | Roberts Brigette | +133,615 | - | - |
| 2026-05-18 | Roberts Brigette | +362,092 | - | - |
| 2026-05-18 | Roberts Brigette | +69,350 | - | - |
| 2026-05-18 | Roberts Brigette | +124,830 | - | - |
| 2026-05-18 | Roberts Brigette | +228,855 | - | - |
| 2026-05-18 | Roberts Brigette | +34,675 | - | - |
| 2026-01-23 | Hannah Brendan | -365,000 | - | - |
| 2026-01-23 | Thye Dirk | +1,000,000 | - | - |
| 2026-01-23 | Ryan Charles S. | +200,000 | - | - |
| 2026-01-02 | McLoughlin Margaret | +19,547 | - | - |
| 2026-01-02 | Lamond David | +29,423 | - | - |
| 2026-01-02 | Bray June | +18,724 | - | - |
| 2026-01-02 | Senner Christopher J. | +21,810 | - | - |
| 2025-12-26 | Benatti Luca | -50,000 | $3.47 | $173,500 |
| 2025-12-10 | Thye Dirk | +739,885 | - | - |
| 2025-12-10 | Thye Dirk | -739,885 | - | - |
| 2025-12-05 | Hannah Brendan | -25,280 | - | - |
| 2025-12-05 | Hannah Brendan | -2,271 | - | - |
| 2025-12-05 | Hannah Brendan | +25,280 | $0.94 | $23,763 |
| 2025-12-05 | Hannah Brendan | +2,271 | $0.55 | $1,249 |